PPT-7 th IAS Conference on HIV Pathogenesis, Treatment and Prevention

Tracking the HIVAIDS epidemic in Asia and the Pacific Mr JVR Prasada Rao UN Secretary General Special Envoy on HIVAIDS in Asia Pacific 3 July 2013 Kuala Lumpur Malaysia . Module 1: . Basic definitions. www.icad-cisd.com. Objectives . This workshop will:. Increase the capacity of media representatives to report on NPT trials with accuracy and sensitivity. Build skills amongst community-based organizations to critically analyze media discourse about HIV prevention trials. B. erber . Hettinga. , UWC, RSA. ISS Conference, 21 August 2013. 1. ISS Conference August 2013. Introduction. The obligation to prevent torture. The obligation to establish independent oversight under UNCAT, OPCAT and RIG. S Abdool Karim. Director. : CAPRISA. Pro Vice-Chancellor (Research): University of KwaZulu-Natal. Professor in Clinical Epidemiology, Columbia University. Associate Member, . Ragon. Institute of MGH, MIT and Harvard. HHS Prevention Targets Pathogenesis Epidemiology Core Supplemental – Process–Outcome &#x/MCI; 0 ;&#x/MCI; 0 ;Background: Impact of CAUTI &#x/MCI; 1 ;&#x/MCI; 1 ;• & Pathogenesis of Bacterial InfectionMicrobiology 86Notes PATHOGENESIS OF BACTERIAL 8.1INTRODUCTION nature of the species or strain (virulence factors) and the number of organisms OBJECTIVES After readi How policies and repressive law-enforcement fuel the HIV epidemic among people who inject drugs . . Professor Kate Dolan. Program of International Research and Training. National Drug and Alcohol Research Centre . UCLA. . . Department of Family Medicine . Treatment of Substance Use Disorders as HIV Prevention . Introduction. Access to HIV services as key component of HIV response among sex workers. Vital elements of HIV prevention and care continuum (HIV prevention, testing and treatment). Challenges to sex workers’ access to HIV related services in Europe. Program Development and Quality Improvement Branch. Infertility Prevention Project. Region I. Wells Beach, Maine. June 4-5, 2012. National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention. Isabelle Andrieux-Meyer, MD. Médecins Sans Frontières . IAS Kuala Lumpur, July 2. nd. 2013. . Prevention strategies for HIV/HCV co infection. Epidemiological burden of HCV/HIV co-infection. Access to HCV screening. Thomas M. . Walent. O.D.. Optometry Resident – VAMC. Wilkes-Barre, PA. March 30, 2012. Case History. March 3, 2005. 41 W/M reports acute visual distortion OD x 1 week. More noticeable with near objects than far . Joseph J. Eron, Jr, MD. Professor of Medicine. University of North Carolina. Chapel Hill, North Carolina. Financial Relationships With Commercial Entities. Dr Eron has served as an ad hoc consultant to Janssen, ViiV Healthcare, Merck, and Gilead Sciences, Inc. His institution receives contracts for clinical research on which Dr Eron is the local principal investigator from Janssen Therapeutics, ViiV Healthcare, and Gilead Sciences, Inc. John T. Brooks, MD . Senior Medical Advisor, CDC Division of HIV/AIDS Prevention. Dr. Brooks has no relevant financial affiliations to disclose. Sexual Transmission Reduced with Lower Blood Viral Load. No Borders – Unifying the Global Workforce . The Impact of drug use…. No Borders. Q. What do all of these threats share in common? . A. They do not respect borders, sovereignty, and affect all nations. .